Australia markets closed

Syngen Biotech Co.,Ltd. (8279.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
150.00-1.00 (-0.66%)
At close: 11:31AM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 4.07B
Enterprise value 4.34B
Trailing P/E 15.56
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.19
Price/book (mrq)1.98
Enterprise value/revenue 2.33
Enterprise value/EBITDA 10.15

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 3-18.92%
S&P500 52-week change 322.38%
52-week high 3191.50
52-week low 3148.00
50-day moving average 3156.19
200-day moving average 3159.45

Share statistics

Avg vol (3-month) 38.69k
Avg vol (10-day) 34.7k
Shares outstanding 527.1M
Implied shares outstanding 629.4M
Float 8N/A
% held by insiders 165.92%
% held by institutions 12.79%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 45
Forward annual dividend yield 43.33%
Trailing annual dividend rate 35.00
Trailing annual dividend yield 33.31%
5-year average dividend yield 41.46
Payout ratio 451.87%
Dividend date 3N/A
Ex-dividend date 429 June 2023
Last split factor 21100:1000
Last split date 309 July 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 14.96%
Operating margin (ttm)15.46%

Management effectiveness

Return on assets (ttm)6.13%
Return on equity (ttm)13.33%

Income statement

Revenue (ttm)1.84B
Revenue per share (ttm)67.79
Quarterly revenue growth (yoy)-10.30%
Gross profit (ttm)N/A
EBITDA 386.21M
Net income avi to common (ttm)274.83M
Diluted EPS (ttm)9.65
Quarterly earnings growth (yoy)-17.10%

Balance sheet

Total cash (mrq)366.89M
Total cash per share (mrq)13.54
Total debt (mrq)538.49M
Total debt/equity (mrq)25.26%
Current ratio (mrq)1.94
Book value per share (mrq)78.65

Cash flow statement

Operating cash flow (ttm)415.13M
Levered free cash flow (ttm)248.24M